Stable and Independent Communication Brain-computer Interfaces
Primary Purpose
Healthy, Tetraplegia, Locked-in Syndrome
Status
Terminated
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Stable and Independent Brain-computer Interfaces for Communication
Sponsored by
About this trial
This is an interventional supportive care trial for Healthy
Eligibility Criteria
Inclusion criteria for healthy persons:
- Older than 18
- Fluent in French, English, German or Italian
- Good visual acuity
Inclusion criteria for people with tetraplegia:
- Older than 18
- Fluent in French, English, German or Italian
- Good visual acuity
- Diagnosed with spinal cord injury, brainstem stroke, spinal stroke, muscular dystrophy or other non-degenerative motor neuron disorders
- Limited or no ability to use both hands - less than grade 4 muscle strength in elbow extension and wrist extension and less than grade 2 strength in finger flexor and abduction on both sides
Inclusion criteria for people with locked-in syndrome:
- Were fluent in French, English, German or Italian before losing the ability to speak
- Enough visual capability to see large letters from a distance of around 50cm according to caretaker's or guardian's opinion
Exclusion criteria for healthy persons:
- Smokers
- Substance or alcohol abuse
- Neurological or psychiatric illness
- History of cranio-facial surgery
- Metallic implants that would prohibit the subject from having a MRI scan
- Medications that may retard motor coordination and cognitive ability (such as sedatives)
- Seizure disorders
- Treated with anti-epileptic medications
Exclusion criteria for people with tetraplegia and locked-in syndrome:
- Disabling neurological illness other than tetraplegia or locked-in syndrome
- Disabling psychiatric illness
- History of cranio-facial surgery
Sites / Locations
- University of Geneva, Campus Biotech
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Stable and Independent Communication Brain-computer Interfaces
Arm Description
Each arm will receive the same intervention.
Outcomes
Primary Outcome Measures
Brain-computer interface stability
The investigators will measure the text-entry rate achieved using the brain-computer interface in each session by the number of correct characters per minute (CCPM). At the end of the study, the investigators will calculate the average brain-computer interface performance, and the correlation between the performance and the duration of brain-computer interface use (performance-use correlation). Brain-computer interface stability will be established if the performance-use correlation is greater than -0.5 CCPM/year. Primary objective of the study will be met if the brain-computer interface performance is stable for 75% of participants or more in each of three study populations, and if the average brain-computer interface performance for participants that show stable performance is greater than 5 CCPM.
Secondary Outcome Measures
Brain-computer interface performance comparison
At the end of the study, the investigators will compare the brain-computer interface performance and the performance-use correlation between the three study populations.
Full Information
NCT ID
NCT03213561
First Posted
July 7, 2017
Last Updated
March 26, 2020
Sponsor
Tomislav Milekovic
Collaborators
University of Geneva, Switzerland, Centre Hospitalier Universitaire Vaudois, University Hospital, Geneva, Wyss Center for Bio and Neuroengineering
1. Study Identification
Unique Protocol Identification Number
NCT03213561
Brief Title
Stable and Independent Communication Brain-computer Interfaces
Official Title
Stable and Independent Non-invasive Communication Brain-computer Interfaces Based on Error-adaptive Decoding Algorithms
Study Type
Interventional
2. Study Status
Record Verification Date
March 2020
Overall Recruitment Status
Terminated
Why Stopped
We have not succeeded in developing an approach that uses hdEEG to control a communication interface at an accuracy needed to complete the protocol.
Study Start Date
July 11, 2017 (Actual)
Primary Completion Date
November 22, 2019 (Actual)
Study Completion Date
November 22, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Tomislav Milekovic
Collaborators
University of Geneva, Switzerland, Centre Hospitalier Universitaire Vaudois, University Hospital, Geneva, Wyss Center for Bio and Neuroengineering
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
People with locked-in syndrome cannot move their limbs or talk because of a motor impairment, but remain conscious and intellectually awake. Restoring the ability to communicate to people with locked-in syndrome will have a positive effect on their quality of life, will enable them to reintegrate into society and increase their capacity to lead productive and fulfilling lives. This study sims to develop a new assisted communication device based on a brain-computer interface, a system that allows the user to control a computer with his brain activity. The investigators will develop this brain-computer system for long-term stability and independent use by using adaptive decoders. The investigators will test the long-term stability and independence of this system with healthy volunteers, people with tetraplegia and people with locked-in syndrome over time periods of several months.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy, Tetraplegia, Locked-in Syndrome
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Masking
None (Open Label)
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Stable and Independent Communication Brain-computer Interfaces
Arm Type
Experimental
Arm Description
Each arm will receive the same intervention.
Intervention Type
Device
Intervention Name(s)
Stable and Independent Brain-computer Interfaces for Communication
Intervention Description
The participants will perform an MRI head scan, which the investigators will use to construct 3D head models of participants. The investigators will use these modele to reconstruct the activity of brain sources from EEG signals. The participants will then take part in a series of EEG recording sessions. During the initial "calibration" sessions, the participants will react with real or attempted movements to visual cues. The investigators will use the EEG signals from these sessions to calibrate the text-entry interface used in the validation sessions that follow. During the validation sessions, the participants will control the text-entry interface to write messages using their EEG signals.
Primary Outcome Measure Information:
Title
Brain-computer interface stability
Description
The investigators will measure the text-entry rate achieved using the brain-computer interface in each session by the number of correct characters per minute (CCPM). At the end of the study, the investigators will calculate the average brain-computer interface performance, and the correlation between the performance and the duration of brain-computer interface use (performance-use correlation). Brain-computer interface stability will be established if the performance-use correlation is greater than -0.5 CCPM/year. Primary objective of the study will be met if the brain-computer interface performance is stable for 75% of participants or more in each of three study populations, and if the average brain-computer interface performance for participants that show stable performance is greater than 5 CCPM.
Time Frame
3 years
Secondary Outcome Measure Information:
Title
Brain-computer interface performance comparison
Description
At the end of the study, the investigators will compare the brain-computer interface performance and the performance-use correlation between the three study populations.
Time Frame
3 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria for healthy persons:
Older than 18
Fluent in French, English, German or Italian
Good visual acuity
Inclusion criteria for people with tetraplegia:
Older than 18
Fluent in French, English, German or Italian
Good visual acuity
Diagnosed with spinal cord injury, brainstem stroke, spinal stroke, muscular dystrophy or other non-degenerative motor neuron disorders
Limited or no ability to use both hands - less than grade 4 muscle strength in elbow extension and wrist extension and less than grade 2 strength in finger flexor and abduction on both sides
Inclusion criteria for people with locked-in syndrome:
Were fluent in French, English, German or Italian before losing the ability to speak
Enough visual capability to see large letters from a distance of around 50cm according to caretaker's or guardian's opinion
Exclusion criteria for healthy persons:
Smokers
Substance or alcohol abuse
Neurological or psychiatric illness
History of cranio-facial surgery
Metallic implants that would prohibit the subject from having a MRI scan
Medications that may retard motor coordination and cognitive ability (such as sedatives)
Seizure disorders
Treated with anti-epileptic medications
Exclusion criteria for people with tetraplegia and locked-in syndrome:
Disabling neurological illness other than tetraplegia or locked-in syndrome
Disabling psychiatric illness
History of cranio-facial surgery
Facility Information:
Facility Name
University of Geneva, Campus Biotech
City
Geneva
ZIP/Postal Code
1202
Country
Switzerland
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Stable and Independent Communication Brain-computer Interfaces
We'll reach out to this number within 24 hrs